Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Oncologists Stories

2013-04-16 12:23:10

ALBANY, N.Y., April 16, 2013 /PRNewswire-USNewswire/ -- Three physician scientists whose landmark research helped transform the treatment of cancer are the recipients of the prestigious Albany Medical Center Prize in Medicine and Biomedical Research, to be officially awarded May 17. The $500,000 award, given to those who have altered the course of medical research, is one of the largest prizes in medicine and science in the United States. This year, the prize will recognize...

2013-04-15 08:28:54

SAN DIEGO, April 15, 2013 /PRNewswire/ -- Ambit Biosciences Corporation today announced that David R. Parkinson, M.D., has been appointed to the company's board of directors. Dr. Parkinson is a venture partner at New Enterprise Associates, a position he has held since 2012, and a member of the board of directors for Threshold Pharmaceuticals, a publicly-traded oncology company, and Zyngenia, Inc. He served as a director of Facet Biotech through its acquisition by Abbott in 2010. Prior to...

2013-04-10 23:02:57

ACF Welcomes Prominent Veterinary and Human Oncologists to its Scientific Advisory Council. The Council Advises the Executive Board on Comparative Oncology Award Grant Criteria and Evaluation. Norwalk, Connecticut (PRWEB) April 10, 2013 Animal Cancer Foundation (ACF) has appointed several prominent leaders in the veterinary and human oncology field to serve as Scientific Advisory Council to its Executive Board. (http://www.acfoundation.org/about/council.php) The Scientific Advisory...

2013-04-10 23:02:47

On Friday, May 10th, The Foundation of Hope and Innovation will have a Casino Night Fundraiser to raise money for cancer research. Downey, California (PRWEB) April 10, 2013 Being held in the lobby of the Downey Regional Medical Plaza at 11480 Brookshire Avenue, Downey, California, attendees of this “Casino Night” fundraiser can expect a fun-filled night of casino games, such as black jack, roulette, and craps. At the end of the evening, gaming chips will be converted into...

2013-04-09 12:29:00

BURLINGAME, Calif., April 9, 2013 /PRNewswire/ -- Igenica, Inc., an innovative biopharmaceutical company focused on the discovery and development of first-in-class antibody-based therapeutics for the treatment of cancer, today announced the appointment of Thi-Sau Migone, Ph.D., to the role of Chief Scientific Officer. Dr. Migone brings wide-ranging experience in the discovery and development of novel therapeutic antibodies. Dr. Migone joins Igenica from Human Genome Sciences,...

2013-04-08 08:25:14

DETROIT, April 8, 2013 /PRNewswire-USNewswire/ -- Ulka Vaishampayan, M.D., leader of the Genitourinary Oncology Multidisciplinary Team at the Barbara Ann Karmanos Cancer Center, has contributed to an article just published in The New England Journal of Medicine comparing two different therapeutic methods in the treatment of metastatic, hormone-sensitive prostate cancer that becomes unresponsive to traditional methods of therapy. (Logo: http://photos.prnewswire.com/prnh/20071106/KARMANOSLOGO)...

2013-04-02 16:25:49

BALTIMORE, April 2, 2013 /PRNewswire/ -- Chesapeake Urology Associates, PA, the premier urology practice in Maryland and the Mid-Atlantic region, has launched a comprehensive website devoted strictly to its Prostate Cancer Care Program. The site, with a URL of http://prostatecancer.chesapeakeurology.com, is an easy-to-access body of information that was built for prostate cancer patients and consumers alike. It provides detail on how prostate cancer is diagnosed, treatment options for...

2013-03-28 12:30:41

Dr. Brodie Best Known for Role in Developing Aromatase Inhibitors BALTIMORE, March 28, 2013 /PRNewswire-USNewswire/ -- Angela H. Brodie, Ph.D., a University of Maryland scientist whose research paved the way for a new class of drugs widely used to treat breast cancer patients around the world, has been selected by the American Association for Cancer Research (AACR) as a fellow of the newly created AACR Academy. Dr. Brodie, professor of pharmacology at the University of Maryland School...

2013-03-25 12:26:34

EXTON, Pa., March 25, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceuticals issues, finds that, despite the 2012 launch of Medivation/Astellas Pharma's Xtandi (enzalutamide) for the treatment of docetaxel-pretreated metastatic castrate-resistant prostate cancer (mCRPC), surveyed oncologists report that Johnson & Johnson/Janssen Biotech/Janssen-Cilag's Zytiga continues to dominate the second-line mCRPC...

2013-03-07 12:20:10

LINTHICUM, Md., March 7, 2013 /PRNewswire-USNewswire/ -- Today, the American Urological Association (AUA), a leading advocate for the specialty of urology, is pleased to announce its support for newly introduced legislation designed to address urotrauma, a growing concern among active military personnel and veterans. The bill, H.R. 984, was formally introduced by Congressman Brett Guthrie (R-KY-2) on March 6, 2013. Urotrauma is a significant issue, particularly among active military...